Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Calcineurin activity

Known as: calcineurin, protein phosphatase type 2B activity 
 
National Institutes of Health

Related topics

Related topics

3 relations
Calcineurin

Broader (2)

calcium-dependent protein serine/threonine phosphatase activityprotein serine/threonine phosphatase activity

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application…
BACKGROUND Therapeutic drug monitoring of calcineurin inhibitor, tacrolimus (TAC), is routinely used in post-transplantation… Expand
Is this relevant?
2018
2018
Extended Release Tacrolimus (LCP-TAC) Prolongs Calcineurin Activity Inhibition During Drug Doses Intervals
Introduction Tacrolimus (TAC) is the cornerstone calcineurin inhibitors most commonly used in renal transplantation. New extended… Expand
Is this relevant?
2015
2015
Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1.
Calcineurin (CN) is the target of the immunophilin-immunosuppressant complex, cyclophilin/cyclosporin A (CyP/CsA). RCAN1 has… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2014
2014
Population PKPD of voclosporin in renal allograft patients.
The aims of this population-pharmacokinetic/pharmacodynamic (POP-PKPD) analysis of voclosporin in renal allograft patients were… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Assessment of immune function in Down syndrome patients
In Down syndrome (DS), trisomy 21 leads to overexpression of gene coding for specific enzymes. This overexpression translates… Expand
  • figure 1
  • table 1
  • table 2
Is this relevant?
2008
2008
Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
During the early post-transplantation period, the limitations of monitoring current tacrolimus dose with classic pharmacokinetics… Expand
Is this relevant?
2006
2006
Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidant
Recent reports on the involvement of calcineurin in cardiac hypertrophy and its susceptibility to free radicals, prompted us to… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Utrophin has been studied extensively in recent years in an effort to find a cure for Duchenne muscular dystrophy. In this… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
BACKGROUND There is a correlation between cyclosporine (CsA) pharmacokinetics (PK) and pharmacodynamics (PD), especially 2 hours… Expand
Is this relevant?
2003
2003
Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil.
BACKGROUND Graft survival depends on adequate immunosuppression. To evaluate the effect on the immune system of immunosuppressive… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE